T2 Biosystems Company Profile (NASDAQ:TTOO)

Analyst Ratings

Consensus Ratings for T2 Biosystems (NASDAQ:TTOO) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $11.35 (117.10% upside)

Analysts' Ratings History for T2 Biosystems (NASDAQ:TTOO)
Show:
DateFirmActionRatingPrice TargetActions
7/20/2016WBB SecuritiesUpgradeBuy -> Strong-Buy$11.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2016Janney Montgomery ScottReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2016BTIG ResearchDowngradeBuy -> Sell$12.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2015Goldman Sachs Group Inc.Boost Price TargetNeutral$13.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Jefferies GroupReiterated RatingBuy -> Fair Value$21.00 -> $11.48View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for T2 Biosystems (NASDAQ:TTOO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/2/2016Q1($0.54)($0.55)$1.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2016Q4($0.59)($0.56)$1.21 million$1.01 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q3($0.59)($0.57)$0.66 million$1.05 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.57)($0.54)$0.34 million$0.56 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.57)($0.53)$0.22 million$0.19 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q414($0.44)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.58)($0.71)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for T2 Biosystems (NASDAQ:TTOO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.59)($0.55)($0.57)
Q2 20163($0.57)($0.54)($0.55)
Q3 20163($0.53)($0.52)($0.53)
Q4 20163($0.51)($0.46)($0.48)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for T2 Biosystems (NASDAQ:TTOO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for T2 Biosystems (NASDAQ:TTOO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/30/2016Rahul DhandaSVPSell3,589$8.16$29,286.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Rahul DhandaSVPSell7,588$8.01$60,779.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Aisling Capital Iii LpMajor ShareholderBuy307,692$9.75$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015David B ElsbreeDirectorBuy10,000$9.75$97,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2015Polaris Venture Partners V, L.Major ShareholderSell15,399$15.04$231,600.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.22$228,284.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.42$231,284.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.05$240,733.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.26$731,651.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$16.57$497,066.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.25$731,201.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Thomas J LoweryInsiderSell2,000$16.03$32,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$15.91$715,902.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.09$724,001.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.22$243,283.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.28$244,183.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$17.08$768,548.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$18.18$545,363.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$18.22$273,281.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Thomas J LoweryInsiderSell1,000$18.65$18,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Michael J CimaDirectorBuy1,000$18.91$18,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Thomas J LoweryInsiderSell1,471$18.55$27,287.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2015Michael A PfallerInsiderSell15,440$16.31$251,826.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Thomas J LoweryInsiderSell1,000$18.43$18,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015David B ElsbreeDirectorBuy1,450$15.05$21,822.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014David B ElsbreeDirectorBuy1,500$14.75$22,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Aisling Capital Iii LpMajor ShareholderBuy454,545$11.00$4,999,995.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Sarah O KalilCOOBuy15,000$11.00$165,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Thomas J CarellaDirectorBuy909,090$11.00$9,999,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for T2 Biosystems (NASDAQ:TTOO)
DateHeadline
07/22/16 06:48 PMT2 Biosystems Inc Declines Again; Strong Momentum for Sellers - Consumer Eagle
07/22/16 09:52 AMEquity Roundup: Stock Performance Focus on T2 Biosystems, Inc. (NASDAQ:TTOO) - Press Telegraph
07/22/16 09:52 AMAnalysts Upgrade of the Day: T2 Biosystems Inc (NASDAQ:TTOO) - Review Fortune
07/22/16 09:52 AMT2 Biosystems Inc. (TTOO) is Trading Higher on Unusual Volume for July 20 - Equities.com
07/21/16 09:46 AMT2 Biosystems Announces 2016 Second Quarter and Six-Month Results Release and Conference Call Date
07/20/16 08:00 PMShares Jumping Higher in Session: T2 Biosystems, Inc. (NASDAQ:TTOO) - TGP
07/20/16 09:49 AMHow Many T2 Biosystems Inc (NASDAQ:TTOO)'s Analysts Are Bullish? - Consumer Eagle
07/20/16 09:49 AMT2 Biosystems (TTOO) Enters Agreement with Bayer to Provide T2MR - StreetInsider.com
07/20/16 07:11 AMT2 Biosystems upgraded by WBB Securities -
07/18/16 07:54 AMT2 Biosystems Announces Research and Development Collaboration with Bayer to Advance Drug Monitoring and Biomarker ...
07/18/16 07:00 AMT2 Biosystems Announces Research and Development Collaboration with Bayer to Advance Drug Monitoring and Biomarker Discovery for Blood Coagulation Disorders - [GlobeNewswire] - LEXINGTON, Mass., July 18, 2016-- T2 Biosystems, Inc., a company developing innovative diagnostic products to improve patient health, has signed a multi-year agreement to provide T2 Biosystems’ T2 Magnetic ...
07/17/16 06:15 PMT2 Biosystems, Inc. (NASDAQ:TTOO) Yearly Sales Target At $120.843 - Investor Newswire
07/17/16 07:55 AMShares Experiencing a Downtrend: T2 Biosystems, Inc. (NASDAQ:TTOO) - TGP
07/16/16 06:15 PMIncreased Volatility Noted on Shares of: T2 Biosystems, Inc. (NASDAQ:TTOO) - Engelwood Daily
07/16/16 06:15 PMShares Moving Down on the Week: T2 Biosystems, Inc. (NASDAQ:TTOO) - Engelwood Daily
07/16/16 06:15 PMT2 Biosystems Inc. (TTOO) is Trading Higher on Unusual Volume for July 13 - Equities.com
07/14/16 10:36 AMTrading Performance and Target Watch for T2 Biosystems, Inc. (NASDAQ:TTOO) - Press Telegraph
07/13/16 07:17 PMSession Volatility Review for: T2 Biosystems, Inc. (NASDAQ:TTOO) - Engelwood Daily
07/13/16 07:17 PMJulian Robertson More Than Doubles Stake in T2 Biosystems - Yahoo Finance
07/13/16 07:17 PMT2 Biosystems Incorporated (NASDAQ:TTOO) Shorted Shares Increased 7.74% After Market Selling - Consumer Eagle
07/13/16 07:17 PMT2 Biosystems Inc. (TTOO) is Trading Lower on Unusual Volume for July 12 - Equities.com
07/13/16 09:49 AMJulian Robertson More Than Doubles Stake in T2 Biosystems - Nasdaq
07/13/16 09:49 AMT2 Biosystems Inc. (TTOO): Billionaire Julian Robertson's Tiger Management Significantly Increases Its Stake - Insider Monkey (blog)
07/13/16 09:49 AMT2 Biosystems Inc. (TTOO) is Trading Lower on Unusual Volume for July 11 - Equities.com
07/11/16 06:49 PMStock Volatility Focus for: T2 Biosystems, Inc. (NASDAQ:TTOO) - Engelwood Daily
07/11/16 06:49 PMT2 Biosystems Inc. (NASDAQ:TTOO) Is Getting Burned By Analysts - Scibility Media
07/11/16 04:45 PMT2 Biosystems Inc. (TTOO): Billionaire Julian Robertson’s Tiger Management Significantly Increases Its Stake -
07/11/16 07:55 AMStock Rating Watch and Earnings Insight for T2 Biosystems, Inc. (NASDAQ:TTOO) - Press Telegraph
07/11/16 07:55 AMNext Weeks Broker Price Targets For T2 Biosystems, Inc. (TTOO) - Fiscal Standard
07/09/16 09:52 AMT2 Biosystems Cut From Buy To Sell At BTIG
07/08/16 06:51 PMStock Slipping Down in Session: T2 Biosystems, Inc. (NASDAQ:TTOO) - Telanagana Press
07/08/16 06:51 PMT2 Biosystems, Inc. Stock Momentum Hits Extreme Weakness - CML News
07/08/16 09:47 AMCompany Stock Focus for T2 Biosystems, Inc. (NASDAQ:TTOO): Which Way Will Shares Head? - Press Telegraph
07/07/16 03:31 PMT2 Biosystems Announces Preliminary Second Quarter Commercial, Clinical and Executive Personnel Updates - [at noodls] - LEXINGTON, Mass., July 07, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced preliminary commercial ...
07/07/16 03:19 PMT2 BIOSYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Ev -
07/07/16 03:02 PM4:02 pm T2 Biosystems is pushing out the expected timeline for the completion of T2Candida cartridge trial; separately co appoints Joanne Spadoro, Ph.D., as COO -
07/05/16 07:46 AMSales of $130.643 expected for T2 Biosystems, Inc. (NASDAQ:TTOO) - Investor Newswire
07/05/16 07:46 AMShare Performance Recap for: T2 Biosystems, Inc. (NASDAQ:TTOO) - Press Telegraph
07/05/16 07:46 AMBroker Outlook For The Week Ahead T2 Biosystems, Inc. (TTOO) - Fiscal Standard
07/05/16 05:41 AMT2 Biosystems to Present at the Cantor Fitzgerald Healthcare Conference - [at noodls] - LEXINGTON, Mass., July 05, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, and Shawn Lynch, chief financial officer, ...
07/02/16 09:30 AMT2 Biosystems Inc. (TTOO) is Trading Lower on Unusual Volume for June 30 - Equities.com
07/01/16 09:36 AMWBB Securities Upgrades T2 Biosystems Inc to Buy - TheFounders Daily
06/29/16 06:51 PMFlagship Ventures : Names Daniel McIntyre Partner
06/29/16 09:38 AMT2 Biosystems, Inc. (NASDAQ:TTOO) Company Rating and Target Watch - Telanagana Press
06/29/16 09:38 AMNew Broker Ratings For T2 Biosystems, Inc. (TTOO) - FTSE News
06/27/16 06:47 PMShare Update and Earnings Review for T2 Biosystems, Inc. (NASDAQ:TTOO) - Press Telegraph
06/27/16 11:09 AMGenMark, T2 And Accelerate Diagnostics Impress Analysts At Microbiology Forum - Canaccord Genuity provided some remarks on three companies after attending the "American Society for Microbiology" forum. According to the report published Monday, the Canaccord Genuity analysts are positive on GenMark Diagnostics, Inc (NASDAQ: GNMK) and T2 Biosystems Inc (NASDAQ: TTOO), and they expect Accelerate Diagnostics Inc (NASDAQ: AXDX) to remain a key player to follow in 2016–2017. Related Link: NantHealth ...Full story available on Benzinga.com
06/27/16 07:25 AMT2 Biosystems, Inc. (TTOO) Broker Price Targets For The Coming Week - Fiscal Standard
06/26/16 07:55 AMT2 Biosystems Incorporated (NASDAQ:TTOO) Sellers Increased By 3.81% Their Shorts - Engelwood Daily
06/26/16 07:55 AMT2 Biosystems, Inc. (NASDAQ:TTOO) Earnings Glance and Target Price Review - Engelwood Daily

Social

About T2 Biosystems

T2 Biosystems logoT2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TTOO
  • CUSIP:
Key Metrics:
  • Previous Close: $5.23
  • 50 Day Moving Average: $7.397
  • 200 Day Moving Average: $8.532
  • P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $128.75M
  • Beta: 2.15
  • Current Year EPS Consensus Estimate: $-2.14 EPS
  • Next Year EPS Consensus Estimate: $-1.15 EPS
Additional Links:
T2 Biosystems (NASDAQ:TTOO) Chart for Tuesday, July, 26, 2016